HCAT vs. COUR, QUBT, FSLY, MOMO, HUYA, EVER, BBAI, VTEX, BLND, and VMEO
Should you be buying Health Catalyst stock or one of its competitors? The main competitors of Health Catalyst include Coursera (COUR), Quantum Computing (QUBT), Fastly (FSLY), Hello Group (MOMO), HUYA (HUYA), EverQuote (EVER), BigBear.ai (BBAI), VTEX (VTEX), Blend Labs (BLND), and Vimeo (VMEO). These companies are all part of the "computer software" industry.
Health Catalyst vs.
Health Catalyst (NASDAQ:HCAT) and Coursera (NYSE:COUR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, community ranking, earnings and media sentiment.
85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 89.6% of Coursera shares are held by institutional investors. 2.5% of Health Catalyst shares are held by insiders. Comparatively, 16.3% of Coursera shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Coursera has higher revenue and earnings than Health Catalyst. Coursera is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.
Health Catalyst received 54 more outperform votes than Coursera when rated by MarketBeat users. However, 69.87% of users gave Coursera an outperform vote while only 67.63% of users gave Health Catalyst an outperform vote.
In the previous week, Coursera had 2 more articles in the media than Health Catalyst. MarketBeat recorded 5 mentions for Coursera and 3 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 1.26 beat Coursera's score of 0.39 indicating that Health Catalyst is being referred to more favorably in the media.
Health Catalyst has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500. Comparatively, Coursera has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500.
Health Catalyst currently has a consensus target price of $9.27, suggesting a potential upside of 113.90%. Coursera has a consensus target price of $10.13, suggesting a potential upside of 41.05%. Given Health Catalyst's stronger consensus rating and higher possible upside, equities analysts plainly believe Health Catalyst is more favorable than Coursera.
Coursera has a net margin of -11.45% compared to Health Catalyst's net margin of -26.20%. Health Catalyst's return on equity of -7.51% beat Coursera's return on equity.
Summary
Coursera beats Health Catalyst on 9 of the 17 factors compared between the two stocks.
Get Health Catalyst News Delivered to You Automatically
Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Health Catalyst Competitors List
Related Companies and Tools
This page (NASDAQ:HCAT) was last updated on 3/20/2025 by MarketBeat.com Staff
